147 related articles for article (PubMed ID: 22897138)
1. Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus.
Njerve IU; Pettersen AÅ; Opstad TB; Arnesen H; Seljeflot I
Metab Syndr Relat Disord; 2012 Dec; 10(6):400-6. PubMed ID: 22897138
[TBL] [Abstract][Full Text] [Related]
2. Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.
Zhang X; Feng X; Cai W; Liu T; Liang Z; Sun Y; Yan C; Han Y
Thromb Res; 2015 Jun; 135(6):1147-53. PubMed ID: 25845619
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS; Suh DW; Ha KY
Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
[TBL] [Abstract][Full Text] [Related]
4. Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.
Yadav AK; Lal A; Jha V
J Atheroscler Thromb; 2011; 18(11):958-65. PubMed ID: 21873805
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
Shah R; Hinkle CC; Ferguson JF; Mehta NN; Li M; Qu L; Lu Y; Putt ME; Ahima RS; Reilly MP
Diabetes; 2011 May; 60(5):1512-8. PubMed ID: 21525510
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
7. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
[TBL] [Abstract][Full Text] [Related]
8. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease.
Wong BW; Wong D; McManus BM
Cardiovasc Pathol; 2002; 11(6):332-8. PubMed ID: 12459434
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris.
Ikejima H; Imanishi T; Tsujioka H; Kashiwagi M; Kuroi A; Tanimoto T; Kitabata H; Ishibashi K; Komukai K; Takeshita T; Akasaka T
Circ J; 2010 Feb; 74(2):337-45. PubMed ID: 20019415
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.
Njerve IU; Byrkjeland R; Arnesen H; Åkra S; Solheim S; Seljeflot I
Diabetes Metab Syndr Obes; 2016; 9():55-62. PubMed ID: 27042130
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection.
Njerve IU; Solheim S; Lunde K; Hoffmann P; Arnesen H; Seljeflot I
Cytokine; 2014 Sep; 69(1):131-5. PubMed ID: 24930044
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
15. Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.
Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
J Diabetes Complications; 2013; 27(3):255-61. PubMed ID: 23182401
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
[TBL] [Abstract][Full Text] [Related]
17. Role of fractalkine in the pathogenesis of primary Sjögren syndrome: increased serum levels of fractalkine, its expression in labial salivary glands, and the association with clinical manifestations.
Lee JH; Kwok SK; Jung SM; Lee J; Lee JS; Baek SY; Kim EK; Ju JH; Park SH; Kim HY
J Rheumatol; 2014 Dec; 41(12):2425-38. PubMed ID: 25320221
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
19. Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease.
Gao L; Xu Z; Yin Z; Chen K; Wang C; Zhang H
Inflamm Res; 2015 Aug; 64(8):627-35. PubMed ID: 26123579
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure.
Hildemann SK; Schulz C; Fraccarollo D; Schöpp C; Flierl U; Wissel K; Pelisek J; Massberg S; Bauersachs J; Schäfer A
Thromb Haemost; 2014 Apr; 111(4):725-35. PubMed ID: 24336891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
